Clinical Trials List
2006-06-01 - 2008-06-30
Phase I
Terminated3
ICD-10I69.092
Facial weakness following nontraumatic subarachnoid hemorrhage
ICD-10I69.093
Ataxia following nontraumatic subarachnoid hemorrhage
ICD-10I69.098
Other sequelae following nontraumatic subarachnoid hemorrhage
ICD-10I69.192
Facial weakness following nontraumatic intracerebral hemorrhage
ICD-10I69.193
Ataxia following nontraumatic intracerebral hemorrhage
ICD-10I69.198
Other sequelae of nontraumatic intracerebral hemorrhage
ICD-10I69.292
Facial weakness following other nontraumatic intracranial hemorrhage
ICD-10I69.293
Ataxia following other nontraumatic intracranial hemorrhage
ICD-10I69.298
Other sequelae of other nontraumatic intracranial hemorrhage
ICD-10I69.392
Facial weakness following cerebral infarction
ICD-10I69.393
Ataxia following cerebral infarction
ICD-10I69.398
Other sequelae of cerebral infarction
ICD-10I69.892
Facial weakness following other cerebrovascular disease
ICD-10I69.893
Ataxia following other cerebrovascular disease
ICD-10I69.898
Other sequelae of other cerebrovascular disease
ICD-10I69.992
Facial weakness following unspecified cerebrovascular disease
ICD-10I69.993
Ataxia following unspecified cerebrovascular disease
ICD-10I69.998
Other sequelae following unspecified cerebrovascular disease
ICD-9438.89
Other late effects of cerebrovascular disease
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 張寓智 Division of Neurology
- Tsong-Hai Lee Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 許立奇 Division of Neurology
- 陸仁安 Division of Neurology
- Chang-Ming Chern Division of Neurology
- 翁文章 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- WEI-JU LEE Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
226 participants
